Direxion Daily S&P Biotech Bear 3X Shares (LABD) |
|
13.48 0.31 (2.35%)
|
02-08 10:05 |
|
Open: |
13.3 |
Pre. Close: |
13.17 |
|
High:
|
13.6 |
Low:
|
13.21 |
|
Volume:
|
1,490,093 |
Market Cap:
|
0(M) |
|
|
|
Technical analysis |
as of: 2023-02-08 9:49:23 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 18.67  One year: 21.42 |
| Support: |
Support1: 12.18 Support2: 10.13 |
| Resistance: |
Resistance1: 15.98 Resistance2: 18.34 |
| Pivot: |
13.89 |
| Moving Average: |
MA(5): 13.1 MA(20): 14.15
MA(100): 19.49 MA(250): 30.79 |
| MACD: |
MACD(12,26): -1.2  Signal(9): -1.2 |
| Stochastic oscillator: |
%K(14,3): 28.9 %D(3): 25 |
| RSI: |
RSI(14): 40.7 |
| 52-week: |
High: 85.27 Low: 12.18 |
| Average Vol(K): |
3-Month: 11,232 (K) 10-Days: 9,703 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LABD ] has closed above bottom band by 35.3%. Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.11 - 14.19 |
14.19 - 14.26 |
|
Low:
|
12.91 - 12.99 |
12.99 - 13.07 |
|
Close:
|
13.05 - 13.18 |
13.18 - 13.3 |
|
Company Description |
|
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified. |
Headline News |
Mon, 23 Jan 2023
Keeping laboratory data secure - Lab News
Fri, 06 Jan 2023
A String of Pearls: Linear Immunoglobulin A (IgA) Bullous ... - Cureus
Tue, 13 Dec 2022
Top Performing Leveraged/Inverse ETFs: 12/11/2022 - ETF Trends
Thu, 03 Nov 2022
LABD: Sell Rating Reaffirmed (NYSEARCA:LABD) - Seeking Alpha
Wed, 02 Nov 2022
LABD: A Bad Bad Drift (NYSEARCA:LABD) - Seeking Alpha
Fri, 28 Oct 2022
LABU: Opportunities For Gains Exist If Bought And Sold At Correct ... - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
